Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.
about
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in noAn increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.
P2860
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Results of the randomized phas ...... b in previously untreated CLL.
@en
Results of the randomized phas ...... b in previously untreated CLL.
@en-gb
Results of the randomized phas ...... b in previously untreated CLL.
@nl
type
label
Results of the randomized phas ...... b in previously untreated CLL.
@en
Results of the randomized phas ...... b in previously untreated CLL.
@en-gb
Results of the randomized phas ...... b in previously untreated CLL.
@nl
prefLabel
Results of the randomized phas ...... b in previously untreated CLL.
@en
Results of the randomized phas ...... b in previously untreated CLL.
@en-gb
Results of the randomized phas ...... b in previously untreated CLL.
@nl
P2093
P2860
P50
P356
P1154
2-s2.0-85030646380
P1433
P1476
Results of the randomized phas ...... ab in previously untreated CLL
@en
P2093
A Hockaday
A S Duncombe
A Varghese
D Milligan
J L O'Dwyer
L McParland
P2860
P2888
P304
P356
10.1038/LEU.2017.96
P5530
P577
2017-03-24T00:00:00Z
P6179
1084128362